Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Obesity01:24

Obesity

1.4K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

298
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
298
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

310
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
310
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

210
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
210
Stress Prevention and Stress Management Techniques IV01:26

Stress Prevention and Stress Management Techniques IV

280
Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
280
Bulimia Nervosa01:30

Bulimia Nervosa

840
Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
840

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Navigating Cardiovascular Health Disparities: The Role of Race and Classification.

Journal of racial and ethnic health disparities·2026
Same author

Not Just Sports and Play: Adolescent Movement Throughout the Day.

Health education & behavior : the official publication of the Society for Public Health Education·2026
Same author

Have sedentary lifestyles reached even remote parts of the Global South? Evidence from school-going adolescents' time use in India.

PloS one·2026
Same author

Corrigendum to "Social factors as buffers for the adverse impact of adverse childhood experiences on biological age acceleration among adults in Hispanic Community Health Study/Study of Latinos" [Brain Behav. Immun. 132 (2026) 106241].

Brain, behavior, and immunity·2026
Same author

Social factors as buffers for the adverse impact of adverse childhood experiences on biological age acceleration among adults in Hispanic Community Health Study / Study of Latinos.

Brain, behavior, and immunity·2025
Same author

Obesity from Childhood to Mid-adulthood in the United States: A Synthetic Cohort Approach to Measuring Health Trajectories.

Epidemiology (Cambridge, Mass.)·2025

Related Experiment Video

Updated: Feb 21, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.3K

Multimorbidity Patterns and Obesity Among Americans Turning Forty.

Xinyu Zhu1, Rebecca Jones-Antwi2, Solveig A Cunningham3,4

  • 1Nutrition and Health Sciences Program, Laney Graduate School, Emory University, Atlanta, GA, USA.

American Journal of Health Promotion : AJHP
|February 19, 2026
PubMed
Summary

Multimorbidity patterns in adults entering their 40s include arthritis-mental health and hypertension-diabetes clusters. Obesity significantly increases the risk for both these prevalent multimorbidity patterns.

Keywords:
chronic diseaseearly midlifelatent class analysismultimorbidityobesity

More Related Videos

Methods for Presenting Real-world Objects Under Controlled Laboratory Conditions
06:54

Methods for Presenting Real-world Objects Under Controlled Laboratory Conditions

Published on: June 21, 2019

6.4K
Assessment of Child Anthropometry in a Large Epidemiologic Study
09:36

Assessment of Child Anthropometry in a Large Epidemiologic Study

Published on: February 2, 2017

28.0K

Related Experiment Videos

Last Updated: Feb 21, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.3K
Methods for Presenting Real-world Objects Under Controlled Laboratory Conditions
06:54

Methods for Presenting Real-world Objects Under Controlled Laboratory Conditions

Published on: June 21, 2019

6.4K
Assessment of Child Anthropometry in a Large Epidemiologic Study
09:36

Assessment of Child Anthropometry in a Large Epidemiologic Study

Published on: February 2, 2017

28.0K

Area of Science:

  • Public Health
  • Epidemiology
  • Chronic Disease Management

Background:

  • Multimorbidity, the simultaneous occurrence of two or more chronic conditions, is a growing public health concern, particularly as individuals age.
  • Understanding the specific patterns of multimorbidity is crucial for developing targeted interventions and healthcare strategies.
  • Adults entering their 40s represent a critical transition period where early signs of chronic disease may emerge.

Purpose of the Study:

  • To identify distinct multimorbidity patterns among U.S. adults around age 40.
  • To investigate the association between obesity and these identified multimorbidity patterns.

Main Methods:

  • Cross-sectional analysis of data from the National Longitudinal Study of Youth 1979 (n=8104).
  • Latent class analysis was used to identify multimorbidity patterns based on self-reported diagnoses of 7 chronic conditions.
  • Multinomial logistic regressions examined the association between obesity (BMI ≥30 kg/m²) and disease clusters.

Main Results:

  • At a mean age of 41, 10.8% of adults had multimorbidity, and 26.3% had obesity.
  • Three multimorbidity patterns were identified: a 'healthy' group (≤1 condition), an 'arthritis-mental health conditions-dominated' cluster (5.6%), and a 'hypertension-diabetes-dominated' cluster (2.4%).
  • Obesity was strongly associated with both multimorbidity clusters, with significantly higher odds for the 'hypertension-diabetes' cluster (OR=5.2) and 'arthritis-mental health' cluster (OR=1.7).

Conclusions:

  • Multimorbidity in U.S. adults in their 40s clusters around arthritis-mental health and hypertension-diabetes conditions.
  • Obesity is a significant risk factor disproportionately affecting individuals within these prevalent multimorbidity clusters.
  • These findings highlight the importance of obesity management in preventing and addressing multimorbidity in midlife adults.